Proactive Investors - Run By Investors For Investors

Tilray shorts fell by about 45,000 in the past week, says S3 Partners

But the drop in the number of shares shorted is not a squeeze in the market
Cannabis workers
The Canadian cannabis company's shares have become a battleground stock

The number of shares that are being shorted in Tilray Inc (NASDAQ:TLRY) has gone down by about 45,000 over the last week, a report by analytics company S3 Partners said on Wednesday.

Ihor Dusaniwsky said in a tweet the short interest in the Canadian cannabis company at this time is worth $385 million and the number of shares shorted stands at 3.57 million, accounting for 34.63% of the bloat.

Dusaniwsky said the fall in the number of shares shorted is “in no way a short squeeze as the stock was down 7% and shorts were up $128 million in mark-to-market profits.”

READ: Waiting to inhale? Cannabis stocks like Tilray are only going to go higher

Borrowing costs are now ranging from 50% to 70% fee, compared with the 500%-700% fee levels at the height of the rally in the stock last week when the share price charged to an all-time peak of $300.

Tilray is a Canadian cannabis company where market bulls and bears are battling it out, with the bulls pointing to the upcoming legalization of cannabis in Canada and short sellers claiming the stock is overvalued.

Shares were trading 4.34% higher at $112.56 late on Wednesday.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TLRY profile View Profile

Tilray Inc Timeline

Related Articles

muffins and cannabis
November 30 2018
Dehydratech is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker, while making them taste and smell better at the same time
Laboratory testing
October 10 2018
Fifteen patients have been enrolled in the trial being carried out at Children’s Hospital of Philadelphia in the USA.
High Hampton Holdings set to add near term revenue to bottom line with Mojave Jane acquisition
November 13 2018
Mojave Jane is a California-licensed manufacturer of premium cannabis extracts and concentrates for buyers in the US state

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use